QuidelOrtho Corp. Stock Plummets to New 52-Week Low at $17.03

QuidelOrtho Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 17.03 on March 18, 2026. This marks a significant decline, with the stock's performance over the past year showing a decrease of 58.58%, starkly contrasting with the S&P 500's gain of 17.99% during the same period. The company's market capitalization stands at USD 1,202 million, and it has been grappling with financial difficulties, as evidenced by its negative results over the last 12 consecutive quarters. Key financial metrics reveal a debt-equity ratio of 1.31, indicating a higher reliance on debt, while the return on equity is reported at -7.95%. Additionally, the stock's price-to-book ratio is 0.63, suggesting it is trading below its book value. QuidelOrtho's performance has consistently lagged behind the benchmark, with a notable decline of 47.18% in returns over the past year. The stock's 52-week high was recorded at USD 38.99, highlighting the extent of its recent downturn.